SK Square Co Ltd
KRX:402340
SK Square Co Ltd
KRX:402340
Price:
544 000
KRW
-2.51%
Market Closed
Market Cap:
₩71.9T
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
SK Square Co Ltd
KRX:402340
|
KR |
|
S
|
Serena Energia SA
BOVESPA:SRNA3
|
BR |
|
D
|
Diagnosticos da America SA
BOVESPA:DASA3
|
BR |
|
Keweenaw Land Association Ltd
OTC:KEWL
|
US |
|
B
|
Balurghat Technologies Ltd
BSE:520127
|
IN |
|
Hiap Tong Corporation Ltd
SGX:5PO
|
SG |
|
C
|
Corline Biomedical AB
STO:CLBIO
|
SE |
|
M
|
MIXUE Group
HKEX:2097
|
CN |
Income Statement
Earnings Waterfall
SK Square Co Ltd
SK Square Co Ltd
Income Statement
SK Square Co Ltd
SK Square Co Ltd
Currency: KRW
| Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||
| Interest Expense |
4 665
|
4 812
|
5 518
|
6 239
|
8 266
|
11 186
|
14 313
|
17 013
|
17 535
|
17 123
|
16 946
|
17 315
|
0
|
|
| Revenue |
2 735 179
N/A
|
1 822 160
-33%
|
599 343
-67%
|
(156 427)
N/A
|
223 915
N/A
|
711 015
+218%
|
1 306 971
+84%
|
1 724 019
+32%
|
1 906 611
+11%
|
1 811 141
-5%
|
1 749 169
-3%
|
1 699 556
-3%
|
1 411 521
-17%
|
|
| Gross Profit | ||||||||||||||
| Cost of Revenue |
(710 584)
|
(818 292)
|
(888 071)
|
(899 949)
|
(873 116)
|
(847 641)
|
(812 222)
|
(767 473)
|
(644 658)
|
(587 446)
|
(553 111)
|
(519 049)
|
(301 887)
|
|
| Gross Profit |
2 024 595
N/A
|
1 003 868
-50%
|
(288 728)
N/A
|
(1 056 376)
-266%
|
(649 201)
+39%
|
(136 626)
+79%
|
494 749
N/A
|
956 546
+93%
|
1 261 953
+32%
|
1 223 695
-3%
|
1 196 058
-2%
|
1 180 507
-1%
|
1 109 634
-6%
|
|
| Operating Income | ||||||||||||||
| Operating Expenses |
(2 008 543)
|
(1 984 007)
|
(1 905 274)
|
(1 828 031)
|
(1 690 497)
|
(1 651 831)
|
(1 574 357)
|
(1 514 081)
|
(1 456 120)
|
(1 386 689)
|
(1 372 698)
|
(1 333 019)
|
(1 242 648)
|
|
| Selling, General & Administrative |
(1 857 444)
|
(1 824 789)
|
(1 749 805)
|
(1 673 611)
|
(1 549 366)
|
(1 487 848)
|
(1 432 964)
|
(1 373 789)
|
(1 313 457)
|
(1 248 631)
|
(1 241 042)
|
(1 207 934)
|
(1 130 298)
|
|
| Research & Development |
(53 973)
|
(54 520)
|
(52 353)
|
(53 132)
|
(52 703)
|
(49 870)
|
(50 049)
|
(48 131)
|
(47 630)
|
(45 711)
|
(43 043)
|
(40 761)
|
(37 778)
|
|
| Depreciation & Amortization |
(97 126)
|
(94 607)
|
(93 025)
|
(91 503)
|
(88 428)
|
(89 931)
|
(91 344)
|
(92 161)
|
(95 033)
|
(92 347)
|
(88 613)
|
(84 324)
|
(74 572)
|
|
| Other Operating Expenses |
0
|
(10 091)
|
(10 091)
|
(9 785)
|
0
|
(24 182)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
16 052
N/A
|
(980 139)
N/A
|
(2 194 002)
-124%
|
(2 884 407)
-31%
|
(2 339 698)
+19%
|
(1 788 457)
+24%
|
(1 079 608)
+40%
|
(557 535)
+48%
|
(194 167)
+65%
|
(162 994)
+16%
|
(176 640)
-8%
|
(152 512)
+14%
|
(133 014)
+13%
|
|
| Pre-Tax Income | ||||||||||||||
| Interest Income Expense |
38 861
|
(533)
|
(26 197)
|
(20 264)
|
(227 674)
|
164 193
|
1 016 952
|
2 216 296
|
4 091 430
|
5 400 660
|
6 146 954
|
7 541 905
|
9 725 758
|
|
| Non-Reccuring Items |
(10 091)
|
0
|
0
|
0
|
(24 182)
|
0
|
(25 051)
|
(25 145)
|
(32 789)
|
(36 730)
|
(36 167)
|
(89 522)
|
(69 787)
|
|
| Gain/Loss on Disposition of Assets |
(714)
|
(872)
|
(738)
|
(701)
|
(1 280)
|
(1 273)
|
(1 231)
|
2 827
|
2 846
|
4 079
|
4 771
|
(926)
|
85 342
|
|
| Total Other Income |
(3 312)
|
(2 971)
|
(5 653)
|
(7 940)
|
(4 686)
|
(2 176)
|
(34 006)
|
(34 112)
|
(31 688)
|
(33 239)
|
(6 986)
|
(4 803)
|
(101 032)
|
|
| Pre-Tax Income |
40 796
N/A
|
(984 515)
N/A
|
(2 226 590)
-126%
|
(2 913 312)
-31%
|
(2 597 520)
+11%
|
(1 627 713)
+37%
|
(122 944)
+92%
|
1 602 331
N/A
|
3 835 632
+139%
|
5 171 776
+35%
|
5 931 932
+15%
|
7 294 142
+23%
|
9 507 267
+30%
|
|
| Net Income | ||||||||||||||
| Tax Provision |
(1 962)
|
49 016
|
117 237
|
145 609
|
292 263
|
247 462
|
180 491
|
51 875
|
(185 117)
|
(242 287)
|
(284 145)
|
(293 122)
|
(673 991)
|
|
| Income from Continuing Operations |
38 834
|
(935 499)
|
(2 109 353)
|
(2 767 703)
|
(2 305 257)
|
(1 380 251)
|
57 547
|
1 654 206
|
3 650 515
|
4 929 489
|
5 647 787
|
7 001 020
|
8 833 276
|
|
| Income to Minority Interest |
3 661
|
44 220
|
48 135
|
59 373
|
27 786
|
34 328
|
36 895
|
30 359
|
63 456
|
55 619
|
36 874
|
32 454
|
5 436
|
|
| Net Income (Common) |
259 768
N/A
|
(700 037)
N/A
|
(1 881 322)
-169%
|
(1 625 825)
+14%
|
(1 287 048)
+21%
|
(411 865)
+68%
|
1 023 840
N/A
|
1 701 000
+66%
|
3 713 971
+118%
|
4 985 108
+34%
|
5 684 661
+14%
|
7 033 474
+24%
|
8 824 131
+25%
|
|
| EPS (Diluted) |
1 837.02
N/A
|
-4 950.37
N/A
|
-13 449.92
-172%
|
-11 740.5
+13%
|
-9 258.6
+21%
|
-3 052.57
+67%
|
7 648.24
N/A
|
12 727.65
+66%
|
27 715.77
+118%
|
37 482.57
+35%
|
42 847.8
+14%
|
53 048.79
+24%
|
66 712.69
+26%
|
|
Switch to:
Switch to:
See Also
Discover More
